Evidence map›Paper›PMID 32679780›Full record

ReviewBiomolecules2020

Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney.

José M Valdivielso, Àuria Eritja, Maite Caus, Milica Bozic

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. N-methyl-D-aspartate receptor inhibition protects against obesity-induced kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Kynurenine pathway in kidney diseases.Pharmacological reports : PR · 2022
    Review
  15. Article
  16. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

José M ValdivielsoVascular and Renal Translational Research Group, Institute for Biomedical Research in Lleida (IRBLleida) and RedInRen Retic, ISCIII, 25196 Lleida, Spain.
Àuria EritjaVascular and Renal Translational Research Group, Institute for Biomedical Research in Lleida (IRBLleida) and RedInRen Retic, ISCIII, 25196 Lleida, Spain.ORCID 0000-0002-4746-8538
Maite CausVascular and Renal Translational Research Group, Institute for Biomedical Research in Lleida (IRBLleida) and RedInRen Retic, ISCIII, 25196 Lleida, Spain.ORCID 0000-0001-9284-5948
Milica BozicVascular and Renal Translational Research Group, Institute for Biomedical Research in Lleida (IRBLleida) and RedInRen Retic, ISCIII, 25196 Lleida, Spain.ORCID 0000-0002-6064-1446
Instituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos III CP19/00027Instituto de Salud Carlos III FI19/00026Instituto de Salud Carlos III PI18/00292Instituto de Salud Carlos III PI18/00610
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBrainGlutamic AcidHumansKidneyReceptors, N-Methyl-D-AspartateSignal TransductionGlutamic AcidReceptors, N-Methyl-D-AspartateglutamatekidneyNMDARreceptorrenal diseasesignaling

Identifiers

PMID32679780
PMCPMC7407907
OpenAlexW3042410571

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.